Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2017 Jul;11(4):839-841.
doi: 10.1177/1932296817695341. Epub 2017 Mar 1.

Commentary Regarding Shapiro, "Nonadjunctive Use of Continuous Glucose Monitors for Insulin Dosing: Is It Safe?"

David Price  1
Affiliations
Comment

Commentary Regarding Shapiro, "Nonadjunctive Use of Continuous Glucose Monitors for Insulin Dosing: Is It Safe?"

David Price. J Diabetes Sci Technol. 2017 Jul.

Abstract

The FDA recently expanded the approved use of Dexcom's G5 Mobile continuous glucose monitoring (CGM) system to allow for diabetes treatment decisions. This decision is expected to reduce the burden of SMBG testing and increase the adoption and persistent use of CGM. The safety of nonadjunctive CGM use was questioned because of sporadic large discrepancies between CGM and SMBG values. These data were viewed in the context of complaints found in the FDA MAUDE database and social media postings. This commentary provides additional perspective on the inferences that can be drawn from these reports and the risk of nonadjunctive use of CGM data.

Keywords: FDA decisions; continuous glucose monitoring; nonadjunctive use; self-monitored blood glucose.

PubMed Disclaimer

Conflict of interest statement

Declaration of Conflicting Interests: The author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: The author is an employee of, and owns stock in, Dexcom, Inc.

Comment in

Comment on

References

    1. Shapiro AR. Nonadjunctive use of continuous glucose monitors for insulin dosing: is it safe? J Diabetes Sci Technol. 2017. - PMC - PubMed
    1. US Food and Drug Administration. FDA expands indication for continuous glucose monitoring system, first to replace fingerstick testing for diabetes treatment decisions [press release]. 2016. Available at: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm534056.htm. Accessed January 11, 2017.
    1. Bedini JL, Wallace JF, Pardo S, Petruschke T. Performance evaluation of three blood glucose monitoring systems using ISO 15197: 2013 accuracy criteria, consensus and surveillance error grid analyses, and insulin dosing error modeling in a hospital setting. J Diabetes Sci Technol. 2016;10(1):85-92. - PMC - PubMed
    1. Hortensius J, van der Bijl JJ, Kleefstra N, Houweling ST, Bilo HJ. Self-monitoring of blood glucose: professional advice and daily practice of patients with diabetes. Diabetes Educ. 2012;38(1):101-107. - PubMed
    1. Boettcher C, Dost A, Wudy SA, et al. Accuracy of blood glucose meters for self-monitoring affects glucose control and hypoglycemia rate in children and adolescents with type 1 diabetes. Diabetes Technol Ther. 2015;17(4):275-282. - PubMed